A class of synthetic drugs called nitazines have been around since the 1950s — but are quickly gaining a foothold in street drugs.
A study has confirmed the effectiveness of a drug that can treat acquired genetic hearing loss. On the 11th, a research team led by Professor Ji Heon-young, Professor Jang Seung-hyun of Yonsei ...
Fall 2025, a new conference focusing on collaborations and innovative discoveries in pharmacology, InnoPharm, was held in San ...
The drug information sheets that the FDA requires companies to produce are living documents that get updated with new ...
Stuart S. Martin, PhD, an internationally recognized breast cancer researcher, has been appointed Chair of the University of Maryland School of Medicine (UMSOM) Department of Pharmacology & Physiology ...
The Trump administration made a deal with pharmaceutical giants Eli Lilly and Novo Nordisk to lower prices for blockbuster ...
More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...
Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of ...
Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts. Export articles to Mendeley Get article recommendations from ACS based on references in your ...
Abstract: Advancement in Artificial intelligence & machine learning have spurred renewed interest in each & every industry. The intelligent automation is a very important reason for the fast ...
WATERTOWN, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced ...